Rising awareness of pet health has emerged as a significant growth for the market.
As pet owners become more informed about the health risks associated with flea and tick infestations such as skin infections, allergic reactions, and the transmission of serious diseases, they are increasingly prioritizing regular veterinary check-ups and preventive treatments. This heightened awareness has led to a surge in demand for effective flea and tick control products, as pet owners seek to protect their pets from potential health issues.
Additionally, the trend of pet humanization where pets are increasingly regarded as family members has fostered a strong inclination towards providing high-quality care. Pet owners are more willing to invest in premium and advanced flea and tick control solutions that promise superior efficacy and safety.
Therefore, rising awareness of pet health, driven by increased education, and increasing pet humanization has significantly contributed to the expansion of the market, as pet owners prioritize preventive healthcare to ensure the well-being of their pets.
Growing awareness of pet health is fueling the expansion of the market.
Informed pet owners are recognizing the health risks associated to the flea and tick infestations, including skin infections, allergic reactions, and serious disease transmission. As a result, they are prioritizing regular vet check-ups and preventive treatments. This increased awareness has spurred a heightened demand for effective flea and tick control products, underscoring pet owners' commitment to safeguarding their pets' health.
The trend of pet humanization, where pets are seen as integral family members, has intensified the focus on premium care. Consequently, pet owners are more inclined to invest in advanced flea and tick control solutions that guarantee enhanced efficacy and safety.
Thus, the heightened awareness of pet health—bolstered by education and the trend of pet humanization—has played a pivotal role in the growth of the market. Pet owners are increasingly emphasizing preventive healthcare to ensure their pets' well-being.
Authors:
Mariam Faizullabhoy, Gauri Wani
Frequently Asked Questions (FAQ) :
Global flea and tick control medication industry was valued at USD 6.7 billion in 2023 and is anticipated to register 7.1% CAGR between 2024 and 2032 due to the rising incidence of flea and tick-borne diseases in pets.
The chewables segment in the market accounted USD 3.2 billion in 2023, due to their convenience, palatability, and effectiveness.
North America flea and tick control medication market was valued at USD 2.4 billion in 2023, driven by high pet ownership rates, heightened awareness of parasite-related health concerns, and a robust veterinary healthcare infrastructure.
Bayer AG, Boehringer Ingelheim International GmbH, Central Garden & Pet Company, Central Life Sciences, Ceva Santé Animale, Ecto Development LLC, Elanco Animal Health Incorporated, and Hartz Mountain Corporation, among others.